CaroGen Corporation Revenue

Biotechnology Research • Farmington, Connecticut, United States • 11-20 Employees

CaroGen Corporation revenue & valuation

Annual revenue	$4,300,000
Revenue per employee	$391,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$13,800,000
Total funding	$6,800,000

Key Contacts at CaroGen Corporation

Bijan Almassian

Cofounder, President & Ceo

Bhaskara Reddy Madina

Associate Director Of Drug Discovery

Valerian Nakaar

Co-Founder, Chief Scientific Officer, Sr. Vice President

Company overview

Headquarters	400 Farmington Ave, Farmington, Connecticut 06032, US
Phone number	+12038155782
Website	carogencorp.com
SIC	283
Keywords	Pharmaceuticals, Vaccines, Immunotherapy, Infectious Disease, Biotherapeutics, Viral Vesicles, Colon Cancer, Hepatitis B, HBV, Animal Health Vaccine
Founded	2012
Employees	11-20
Socials

CaroGen Corporation Email Formats

CaroGen Corporation uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@carogencorp.com), used 50% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@carogencorp.com	50%
{first initial}	j@carogencorp.com	25%
{first name}{last name}	johndoe@carogencorp.com	25%

About CaroGen Corporation

CaroGen Corporation is an emerging biopharmaceutical company with an entirely new vaccine platform technology developed at Yale University School of Medicine. The Company has recently executed an exclusive license with Yale University to the replication proficient virus-like vesicle (VLV) a platform technology for the development of vaccines for worldwide commercialization. The proprietary VLV technology which has been validated in a number of animal models including non-human primates will be employed to create new, potentially first-in-class vaccines that engage the body’s immune system to both recognize and fight off various diseases. Our vision is to control the spread of infectious diseases by using viral-based technology to produce recombinant protein nanoparticle vaccines for viruses, bacteria and parasites. We are dedicated to creating recombinant vaccines to address a broad range of infectious and chronic diseases. The company is developing a portfolio of vaccine candidates targeting hepatitis B virus, and potentially hepatitis C and other viral agents.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

C-Suite

Director

Employees by Department

CaroGen Corporation has 4 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore CaroGen Corporation's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-01-12	9	$6,800,000

Funding Insights

$6,800,000

Total funding amount

$6,800,000

Most recent funding amount

Number of funding rounds

CaroGen Corporation Tech Stack

Discover the technologies and tools that power CaroGen Corporation's digital infrastructure, from frameworks to analytics platforms.

Autoptimize

Performance

Swiper

JavaScript libraries

Google Maps

Maps

MonsterInsights

Analytics

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Yoast SEO

SEO

Google Workspace

Frequently asked questions

CaroGen Corporation is located in Farmington, Connecticut, US.

You can reach CaroGen Corporation at +12038155782.

CaroGen Corporation generates an estimated annual revenue of $4,300,000. This revenue figure reflects the company's market position and business performance in its industry.

CaroGen Corporation has an estimated valuation of $13,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

CaroGen Corporation was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.

CaroGen Corporation has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

CaroGen Corporation has raised a total of $6,800,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at CaroGen Corporation

Bijan Almassian

Cofounder, President & Ceo

Bhaskara Reddy Madina

Associate Director Of Drug Discovery

Valerian Nakaar

Co-Founder, Chief Scientific Officer, Sr. Vice President

4.8

40,000 users